“Effectiveness of Erythropoiesis-Stimulating Agent Therapy With Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients”. 2026. JURNAL FARMASIMED (JFM) 9 (1): 499-507. https://doi.org/10.35451/jfm.v9i1.3691.